Negotiations aimed at securing public health coverage for the weight-loss drug Wegovy in Canada have stalled. Danish pharmaceutical company Novo Nordisk, the manufacturer of Wegovy, declined...
Novo Nordisk plans to launch an oral version of its highly successful weight loss medication, Wegovy (semaglutide), pending approval from the United States Food and Drug...
Africa’s largest pharmaceutical company, Aspen Pharmacare Holdings Ltd., is set to produce affordable generic versions of popular obesity drugs, including Ozempic, Wegovy, and Mounjaro, starting in...
Canadians may soon have access to more affordable versions of medications like Ozempic and Wegovy, with generic options potentially hitting the market as early as January...
